CA2433767C - Anti-microbial composition - Google Patents

Anti-microbial composition Download PDF

Info

Publication number
CA2433767C
CA2433767C CA002433767A CA2433767A CA2433767C CA 2433767 C CA2433767 C CA 2433767C CA 002433767 A CA002433767 A CA 002433767A CA 2433767 A CA2433767 A CA 2433767A CA 2433767 C CA2433767 C CA 2433767C
Authority
CA
Canada
Prior art keywords
microbial
microbial composition
composition according
compound
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002433767A
Other languages
French (fr)
Other versions
CA2433767A1 (en
Inventor
Stephen Brian Falder
David Rawden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Byotrol PLC
Original Assignee
Byotrol PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0100155A external-priority patent/GB2374011C/en
Application filed by Byotrol PLC filed Critical Byotrol PLC
Publication of CA2433767A1 publication Critical patent/CA2433767A1/en
Application granted granted Critical
Publication of CA2433767C publication Critical patent/CA2433767C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2

Abstract

An anti-microbial composition comprising (i) a first compound having a high surface tension of from 20 to 35mN/m, (ii) a second compound having a low surface tension of from 8 to 14mN/m, (iii) a first anti-microbial agent and (iv) a polar solvent, wherein the composition acts substantially to prevent the formation of microbial colonies on or at a surface of the composition.

Description

2 PCT/GB02/00010 ANTI-MICROBIAL COMPOSITION
This invention relates to anti-microbial compositions and to formulations including the anti-microbial compositions.
s Microorganisms can be found in many environments and are known to present health hazards due to infection or contamination.
When microorganisms are present on the surface of a substrate they can to replicate rapidly to form colonies. Virtually all microorganisms replicate in this way. The microbial colonies form a coating, which is known as a biofilm, on the substrate surface. Biofilms are more hazardous to health than individual microorganisms. Some microorganisms also produce polysaccharide coatings, which makes them more difficult to destroy.
is A biofilm can be f~rmed by a single bacterial species but more often biofilms consist of several species of bacteria, as well as fungi, algae, protozoa, debris and corrosion products. Essentially, biofilm may form on any surface exposed to bacteria and some amount of water, which is needed 2o to allow metabolic processes.
Biofilm formation occurs via three distinct stages. The three stages are (i) adhesion or attachment, (ii) proliferation and (iii) biofilm differentiation.
2s Before stage (i) can occur, the microorganisms must be transported to a surface. This occurs by random contact with the surface due to Brownian motion, sedimentation, active transport or chemotaxis. Once the microorganisms have been transported to a surface, initial adhesion to the surface occurs, for example, as a result of Lifshitz-van der Waals forces, 3o acid-base interactions and electrostatic forces between negatively charged microorganisms and positively charged domains.
The microorganisms then excrete extracellular polymers, which form an extracellular polymeric substance composed of polysaccharides, nucleic acids, amphiphilic, humic substances and proteins. The extracellular polymeric substance forms a matrix that interconnects and binds together microorganisms attached to the surrounding surface. Thus, the microorganisms are anchored to .the surface, which can be all kinds of materials such as metals, plastics, soil particles, medical implant materials 1o and tissue.
Once anchored to a surface, biofilm microorganisms carry out a variety of detrimental or beneficial reactions (by human standards), depending on the surrounding environmental conditions. It is, therefore, desirable to remove ~s and/or destroy the biofilm microorganisms on the surface.
The pasteurisation process has been used for a number of years to destroy microorganisms. In this process, the microorganisms are subjected to high temperature and, optionally, high pressure.
Microorganisms can also be removed from surfaces by simple washing and sanitisation of the. surface with fresh water or with soap or simple detergents. Washing removes the majority of the microorganisms but does not prevent the growth of any microorganisms that remain.
as Microorganisms can also be destroyed by contacting them with anti-microbial agents, which are poisonous to microorganisms. A large number of anti-microbial agents are known. For example, bacteriocidal, fungicidal, algicidal, yeasticidal and moldicidal agents are known. The anti-microbial 3o agents can destroy microorganisms that are present in a wide range of environments such as medical, industrial, commercial, domestic and marine environments. Many of the known anti-microbial agents have previously been included in compositions for use in various applications and environments.
s For example, EP-A-0233954 describes a composition for treating a solid material to give it anti-microbial, hydrophilic and anti-static properties.
The composition comprises a quaternary ammonium salt-containing silane, an organopolysiloxane and, optionally, an organic solvent.
to EP-A-0206028 describes a method of promoting the growth of plants. The method comprises applying a specific quaternary ammonium compound, which may be formulated as an aqueous solution.
15 EP-A-0181182 describes an emulsion that comprises water, a water immiscible liquid, a cationic silane and, optionally, a co-surfactant.
WO-A-93/10209 describes a composition for sterilising, disinfecting, cleaning and lubricating medical and dental devices. The composition 2o comprises a water-soluble or water-dispersible disinfecting and/or sterilising agent, a surfactant and a water-soluble polymer having lubricating characteristics.
WO-A-92/21320 describes medicated shampoo compositions that include 25 anti-microbial agents. The compositions include an anti-microbial agent comprising a fatty acid monoester of a polyhydroxyl alcohol, a chelating agent and a cleansing agent.
US-A-5244666 describes a liquid preparation for use as a presurgical skin 3o scrub or wound disinfectant. The preparation comprises a quaternary
3 ammonium compound, a substituted phenolic compound, water and sodium lauryl sulfate.
JP-9175904 describes an agricultural composition that comprises 1,2-s benzisothiazoline-3-on, dimethyl polysiloxane, water and N-t-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide.
The known anti-microbial agents and the compositions that contain these anti-microbial agents destroy microorganisms by a number of different mechanisms.
Chlorinated compounds, such as hypochlorites (bleaches) can act as anti microbial agents. Traditional bleach includes sodium hypochlorite. Sodium hypochlorite breaks down to provide chloride and chlorate. Chlorate is 1 s highly toxic to life forms.
Although bleaches are useful for destroying a wide range of microorganisms, typically they only work for a short term. This is because their efficacy decreases rapidly once they have broken down. Thus, 2o bleaches do not provide long-term passive anti-microbial control and sanitisation. By "passive control" we mean that the substrate counters microbial infection on its own by some property within it, so that it does not require a cleaning regime to be effective at controlling microorganisms.
Furthermore, bleaches can decompose to produce chlorine gas, which is 25 known to be harmful to the environment. Thus, the use of chlorine-containing compounds is to be avoided where possible.
Other known anti-microbial agents include phenol and compounds thereof, arsenene and salts of arsenic. Examples of useful phenol compounds 3o include polychlorinated biphenols, such as triclosan. Other known anti-
4 microbial agents that are commonly used include organic and inorganic salts of heavy metals such as silver, copper or tin. For example, colloidal silver can be used.
s Phenol compounds typically are highly toxic to humans and animals as well as to microorganisms. Consequently the anti-microbial agents are dangerous to handle, and specialist handling, treatment and equipment are therefore required in order to handle these anti-microbial agents safely.
Anti-microbial agents can also be difficult to handle if they are strongly 1o acidic or alkaline. The manufacture and disposal of compositions comprising this type of anti-microbial agent can, therefore, be problematic.
There can also be problems associated with the use of compositions containing highly toxic anti-microbial agents, particularly in consumer materials where it is difficult to ensure that they are used for designated 15 purposes.
Herein, unless the context indicates otherwise, "toxicity" is intended to refer to toxicity to complex organisms such as mammals. References to "toxic"
are to be construed accordingly.
Anti-microbial agents based on phenols and heavy metals typically are only effective against certain microorganisms, such as fungi. Their use is, therefore, limited because they are not effective against all types of microorganism. Additionally, some anti-microbial agents, such as biphenol, 2s do not remain active for extended periods because they are volatile and do not remain on the surface to which they are applied.
Once the anti-microbial agents and/or their breakdown products enter the environment then they can affect the health of life forms that they were not 3o intended to affect. Moreover, the anti-microbial agents and their breakdown
5 products are often highly stable and can cause enviromnental problems for long periods of time. For example, the metal salts produce toxic rinsates, which are poisonous to aquatic life. Once the toxic compounds enter the environment they are not easily broken down and can cause persistent s problems or unknown consequences. For example, colloidal silver, tributyl tin and diuron can remain in the environment for extended periods of time.
The combustion of polychlorinated biphenol compounds produces dioxins, which are harmful to the environment.
1o Other anti-microbial agents currently in use include antibiotic type compounds, such as penicillin. Antibiotics disrupt the biochemistry within microorganisms, fox example by selectively diluting solutions to destroy or inhibit the growth of harmful microorganisms.
1s Although antibiotics are effective, it is currently believed that they may selectively permit the development of resistant strains of the species that they are used against. These resistant strains are then able to reproduce unimpeded by the use of known antibiotics. Thus, there is a growing concern that wide and uncontrolled use of antibiotic materials in the wider 2o environment, as opposed to their controlled use in medical contexts, could produce significant long-term risks. Antibiotics are, therefore, considered inappropriate for general use in a non-medical environment.
There is also a risk that resistant strains can occur with other types of anti-2s microbial agent, which can have a biochemical effect. For example, triclosan resistance is discussed in Chuanchuen et al., "Multidrug Efflux Pumps and Triclosan Resistance in Pseudomonas Aeruginosa", 100' General Meeting of the American Society for Microbiology, May 21-25, LA; Meade et al., "Unique Mechanism of Triclosan Resistance Identif ed in 3o Environmental Isolates", 100'1' General Meeting of the American Society for
6 Microbiology, May 21-25, LA; Suzangar et al., "An Evaluation of Biocide-containing Materials for their Surface Colonisation-resistance and Other Properties", 100' General Meeting of the American Society for Microbiology, May 21-25, LA. ' s Thus, there is a need for an anti-microbial composition that is effective against a wide variety of microorganisms for long periods of time and which can be used safely and conveniently.
1o According to an aspect of the invention there is provided an anti-microbial composition comprising (i) a first compound having a high surface tension of from 20 to 35 mN/m, (ii) a second compound having a low surface tension of from 8 to 14 mN/m, (iii) a first anti-microbial agent and (iv) a polar solvent, wherein the composition acts substantially to prevent the is formation of microbial colonies on or at a surface of the composition.
The anti-microbial composition of the invention is highly effective and works with a broad range of microorganisms.
2o It seems that the anti-microbial composition of the invention works by providing a surface to which microorganisms are substantially prevented from adhering and attaching. In other words, the composition of the invention substantially prevents the occurrence of stage (i) of the biofilm formation process. This means that the microorganisms cannot then 2s multiply and form biofilms.
It is thought that the surface provided by the anti-microbial composition prevents adhesion and attachment of microorganisms due to the interaction of two compounds of high and low surface tension, which have opposing 3o surface tension effects.
7 The prevention of the formation of a biofilm and the greatly reduced and attenuated colonies of microorganisms provides a substantially reduced risk due to infection or contamination. This has the beneficial effect of sanitizing products that incorporate the anti-microbial composition.
s The anti-microbial composition of the invention typically is also able to break down biofilms that have already formed. It seems that the composition of the invention achieves this by dispersing the biofilms and effectively spreading out the cell walls so as to cause them to break down.
1o The composition may also cause thinning and distortion of the biofilm, which makes the biofilm more susceptible to the anti-microbial agents and, therefore, increases the effectiveness of the anti-microbial agents in the composition.
1s As the anti-microbial composition of the invention physically disrupts the adhesion and attachment of a microorganism to a surface, which is a feature that is common to a wide range of microorganisms, including bacteria, fungi and moulds, the composition is effective against a broad range of microorganisms. Thus, an advantage of the anti-microbial composition of 2o the invention is that it is able to prevent a broad range of microorganisms from adhering and attaching to the surface and, therefore, from forming a biofilm. Large numerous colonies are also substantially prevented from forming. Thus, the ability of the colony to grow is substantially reduced or even prevented. The anti-microbial composition of the invention is, 2s therefore, general in its control of microorganisms.
It seems that as well as preventing the growth of colonies, the anti-microbial composition of the invention increases the relative age of the colony because new microorganisms axe prevented from being produced. Thus, the 3o anti-microbial agents of the composition are brought into contact with
8 "older" microorganisms that are more susceptible to anti-microbial agents than newer ones. The anti-microbial agents are, therefore, more effective at lower concentrations than those that are normally used. Thus, the composition of the invention increases the efficacy of. the anti-microbial s action of the anti-microbial agents compared to when they are used alone.
The anti-microbial composition of the invention can easily be incorporated into other materials, such as functional materials. When incorporated into such materials, these become anti-microbial in nature and the surface of the formulation will be modified so as to substantially prevent the microorganisms from adhering and attaching thereto.
Another advantage of the anti-microbial composition is that it need not comprise combinations of materials that are highly toxic to mammals. The ~s anti-microbial agents used in the anti-microbial compositions are typically well known and widely understood and tested anti-microbial agents. The efficacy of the known anti-microbial agents is amplified in the compositions of the invention. Therefore, anti-microbial agents that have a low toxicity can be used in the anti-microbial compositions. In contrast, new anti-2o microbial agents for known techniques of sanitization use "stronger", more toxic and/or little tested materials.
The anti-microbial composition of the invention also does not comprise materials that produce highly persistent residues or rinsates or products that 2s contain heavy metals and their salts. Thus, there is a greatly reduced risk of long term hazards associated with the anti-microbial compositions.
The composition of the invention does not interfere with the biochemical reproductive pathways of the microorganisms it controls. The risk of 3o resistance build up and the development of resistant strains is, therefore,
9 highly unlikely.
The surface tension of the first compound is greater than that of the second compound and is preferably less than the surface tension of water at any s specified temperature. Thus, the first compound can typically act to reduce the surface tension of water. The surface tension of the first compound is from 20 to 35 mN/m at 20°C.
The surface tension of the second compound is from 8 to 14 mN/m at 20°C, 1o more preferably 10 mN/m at 20°C. The low surface tension of the second compound reduces non-specific bonding with other components of the composition, particularly bonding with aqueous or hydrated materials.
The first compound is preferably hydrophobic. The second compound is 1s preferably hydrophilic. This appears to provide a composition that is typically stable in both hydrophobic and hydrophilic materials.
Additionally, the hydrophobic first compound typically attracts the hydrophilic second compound, so as to provide the desired opposing surface tension effects. This combination of properties is thought to create a 2o microscopic turbulent effect that is disruptive to the formation of a biofilm.
The fact that this effect is microscopic means that it has a great efficacy on microorganisms but not on larger macroorganisms.
Whilst it is preferred that the first compound is hydrophobic and the second 2s compound is hydrophilic, it is possible for the first compound to be hydrophilic and the second compound to be hydrophobic.
Preferably, the first compound is a second anti-microbial agent. Thus, as well as contributing to the surface effects, the first compound also acts as an 3o anti-microbial agent. However, the efficacy of the second anti-microbial agent is improved by the inclusion of the other components of the composition.
By the term "anti-microbial agent" we mean any chemical substance that s can destroy microorganisms.
The first and second anti-microbial agents (hereinafter referred to generally as the anti-microbial agents) present in the compositions of the invention are typically well known and have been subject to research by the regulatory 1o authorities. The anti-microbial agents generally have some effect when they are used alone. However, the efficacy of the anti-microbial agents is amplified when they are used in combination with the other components of the compositions of the invention.
Is Preferably, the composition of the invention comprises two or more anti-microbial agents. A typical composition may comprise four anti-microbial agents.
The anti-microbial agents axe preferably of a polar nature. This-enables 2o them to associate with the other components of the composition, for example by hydrogen bonding or non-chemical bonding. This association brings the anti-microbial agents into direct association with the microorganisms as the other components of the composition of the invention themselves associate with the microbial wall. Thus, the anti-2s microbial agents are effective at low concentrations. The anti-microbial agents are not thought to form a chemical bond with the first and second compounds.
Preferably, the composition comprises at least one anti-microbial agent 3o selected from bacteriocidal, fungicidal, algicidal, yeasticidal and moldicidal agents. More preferably, the composition comprises bacteriocidal, fungicidal and moldicidal agents.
The first anti-microbial agent is preferably an amphoteric compound, an s iodophore, a phenolic compound, a quaternary ammonium compound, a hypochlorite or a nitrogen based heterocyclic compound.
The second anti-microbial agent is preferably a surfactant, more preferably a quaternary ammonium compound. Both the first and second anti-1o microbial agents may each comprise a quaternary ammonium compound.
Preferably, the anti-microbial compositions of the invention comprise one or more quaternary ammonium compounds, phenolic compounds and nitrogen based heterocyclic compounds as the anti-microbial agent.
is Quaternary ammonium compounds that are suitable for use in the invention include compounds of formula R1R2R3R4N'~X-, in which one or two of the R
groups are alkyl, optionally substituted by aryl or optionally interrupted by aryl or a heteroatom, such as oxygen, and the other R groups are the same or 2o different and are C~ to C~ alkyl groups.
Preferred quaternary ammonium compounds include benzalkonium halides, aryl ring substituted benzalkonium halides, such as ethyl-substituted benzalkonium halides, and twin chain quaternary ammonium compounds, 25 such as dialkyldimethyl ammonium compounds wherein the two non-methyl alkyl groups are selected from medium and long chain alkyl groups, such as Cg to C12 alkyl, preferably octyl and dodecyl.
Suitable quaternary ammonium compounds in which an R group (i.e. R1, 3o R2, R3, R4) contains a heteroatom include domiphen bromide, benzalkonium chloride and methylbenzalkonium chloride.
Other quaternary ammonium compounds suitable for use in the anti-microbial composition include alkylpyridinium compounds, such as s cetylpyridinium chloride, and bridged cyclic amino compounds such as the hexaminium compounds.
Particularly preferred quaternary ammonium compounds include benzenethanaminiumn N-dodecyl-N,N-dimethylchloride, 1o benzenethanaminiumn N-dodecyl-N,N-dimethyl-N-tetradecylchloride and benzyl-C12-Ci6-alkyldimethyl-ammoniumchloride.
Amphoteric compounds suitable for use in the present invention include long chain N-alkyl derivatives of amino acids. Long chain N-alkyl 15 derivatives of glycine, alanine and beta-amino butyric acid are preferred.
Particularly preferred compounds include dodecyl beta-alanine, dodecyl beta-aminobutyric acid, dodecylamino-di(aminoethylamino)glycine and N-(3-dodecylamino)propylglycine.
2o By the term "iodophores" we mean complexes of iodine or triodine with a carrier, such as a neutral polymer. The carrier typically increases the solubility of iodine in water, provides a sustained release of the iodine and reduces the equilibrium concentrations of free iodine.
2s Suitable polymeric carriers from which iodophores can be prepared include polyvinylpyrrolidone, polyether glycols such as polyethylene glycols, polyvinyl alcohols, polyacrylates, polyamides, polyalkylenes and polysaccharides.
3o Suitable phenolic compounds include methyl, ethyl, butyl, halo and aryl substituted phenol. Preferred phenolic compounds include 2-phenylphenol, 2-benzyl-4-chlorophenol, 2-cyclopentanol-4-chlorophenol, 4-t-amylphenol, 4-t-butylphenol, 4-chloro-2-pentylphenol, 6-chloro-2-pentylphenol, p-chloro-meta-xylenol, 2,4,4-trichloro-2-hydroxydiphenol, thymol, 2-i-propyl-3-methylphenol, chlorothymol, 3-methyl-4-chlorophenol, 2,6-dichloro-4-n-alkyl phenols, 2,4-dichloro-meta-xylenol, 2,4,6-trichlorophenol and 2-benzyl-4-chlorophenol.
Suitable hypochlorites include alkali metal and alkaline earth metal to hypochlorites, such as the hypochlorites of lithium, sodium, potassium and calcium. Other suitable hypochlorites include chlorinated trisodium phosphate and their various hydrates. Other suitable chlorine containing or chlorine releasing agents include chlorine dioxide and its precursors, as well as N,N-dichloro-4-carboxybenzenesulponamide (halazone), 1,3-dichloro-5,5-dimethylhydantoin (halane) and various chloroisocyanuric acid derivatives.
Suitable nitrogen based heterocyclic compounds include pyridine derivatives, such as 4-pyridine carboxylic acid hydrazide, sodium 2-2o pyridinethiol-1-oxide and bis-(2-pyridylthio)zinc-1,I-dioxide, triazoles, thiazoles and imidazoles.
A particularly preferred anti-microbial composition comprises benzenethanaminiumn N-dodecyl-N,N-dimethylchloride, benzenethanaminiumn N-dodecyl-N,N-dimethyl-N-tetradecylchloride, benzyl-C~a-C16-alkyldimethyl-ammoniumchloride, 2-phenylphenol, 2-octyl-ZH-isothiazol-3-one, 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-ZH-isothiazol-3-one.
3o The particular anti-microbial agents selected for use in the composition will vary depending upon the environment in which the composition is intended to be used.
The second compound is preferably chemically inert and has a structure that s attaches to virtually any substrate. The second compound can, therefore, remain at a surface for long periods of time. This means that the composition of the invention can easily be recharged.
The second compound is also capable of associating with the other to components of the composition of the invention by means of non-chemical bonds and typically can adhere to and attract a wide range of polar materials including various anti-microbial agents.
The second compound is preferably a surfactant or oil, more preferably a 15 short chain surfactant or oil. By the term "short chain" we mean C~a to C2o.
Suitable second compounds include silanes, polyethylene glycol, sodium lauryl sulphate, Soya lecathin and preferably siloxanes such as polysiloxanes or silicones.
2o A preferred second compound is polydimethylsiloxane and a particularly preferred second compound is polydimethylhydroxysiloxane. For example, a polydimethylhydroxysiloxane having a viscosity of from 100 to 400 centistokes may be included in the compositions of the invention.
2s Preferably, the composition comprises from 1 to 4 % by volume of the second compound; however other proportions are possible and lie within the scope of the invention.
Suitable polar solvents for use in the composition include water, alcohols, 3o esters, hydroxy and glycol esters, polyols and ketones. It seems that the polar solvent helps to provide a composition that is stable and does not separate out into its various components.
Preferred alcohols for use in the composition include straight or branched chain C1 to CS alcohols, particularly methanol, ethanol, propanol, iso-propanol, n-butanol, sec-butanol, tent-butanol, iso-butanol, 2-methyl-1-butanol, 1-pentanol and amyl alcohol (mixture of isomers).
Preferred esters for use in the composition include methyl acetate, ethyl to acetate, n-propyl acetate, iso-propyl acetate, n-butyl acetate, iso-butyl acetate, sec-butyl acetate, amyl acetate (mixture of isomers), methylamyl acetate, 2-ethylhexyl acetate and iso-butyl isobutyrate.
Preferred hydroxy and glycol esters for use in the composition include methyl glycol acetate, ethyl glycol acetate, butyl glycol acetate, ethyl diglycol acetate, butyl diglycol acetate, ethyl lactate, n-butyl lactate, 3-methoxy-n-butyl acetate, ethylene glycol diacetate, polysolvan O, 2-methylpropanoic acid-2,2,4-trimethyl-3-hydroxypentyl ester, methyl glycol, ethyl glycol, isopropyl glycol, 3-methoxybutanol, butyl glycol, iso-butyl 2o glycol, methyl diglycol, ethyl diglycol, butyl diglycol, isobutyl diglycol, diethylene glycol, dipropylene glycol, ethylene glycol monohexyl ether and diethylene glycol monohexyl ether.
Preferred polyols for use in the composition include ethylene glycol, 2s propylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, hexylene glycol, diethylene glycol, triethylene glycol and dipropylene glycol.
Preferred ketones for use in the composition include isobutyl heptyl ketone, cyclohexanone, methyl cyclohexanone, methyl isobutenyl ketone, pent-30 ozone, acetyl acetone, diacetone alcohol, isophorone, methyl butyl ketone, ethyl propyl ketone, methyl isobutyl ketone, methyl amyl ketone, methyl isoamyl ketone, ethyl butyl ketone, ethyl amyl ketone, methyl hexyl ketone, diisopropyl ketone, diisobutyl ketone, acetone, methyl ethyl ketone, methyl propyl ketone and diethyl ketone.
Particularly preferred polar solvents for use in the composition include isopropanol, diethylene glycol and dipropylene glycol.
Preferably, the composition comprises from 1 to 70 % by volume of the to polar solvent, but since the primary purpose of the solvent is dilution virtually any proportion of polar solvent is believed to be possible within the scope of the invention.
An especially preferred anti-microbial composition comprises 32 % by 1 s volume of a mixture of benzenethanaminiumn N-dodecyl-N,N-dimethylchloride and benzenethanaminiumn N-dodecyl-N,N-dimethyl-N-tetradecylchloride (2.33:1), 6.0 % by volume of a mixture of benzyl-Cla-C16-alkyldimethyl-ammoniumchloride and 2-phenylphenol (2:1), 6.0 % by volume of 2-octyl-2H-isothiazol-3-one, 16.0 % by volume of a mixture of 20 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:l), 1.0 % by volume of a blend of polysiloxanes and balance by volume isopropanol.
Another especially preferred anti-microbial composition comprises 32 % by 25 volume of a mixture of benzenethanaminiumn N-dodecyl-N,N-dimethylchloride and benzenethanaminiumn N-dodecyl-N,N-dimethyl-N-tetradecylchloride (2.33:1), 6.0 % by volume of a mixture of benzyl-C~a-C16-alkyldimethyl-ammoniumchloride and 2-phenylphenol (2:1), 6.0 % by volume of 2-octyl-2H-isothiazol-3-one, 16.0 % by volume of a mixture of 30 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:1), 1.0 % by volume of polydimethylhydroxysiloxane and balance by volume isopropanol.
Another especially preferred anti-microbial composition comprises S.0 s by volume of a mixture of benzenethanaminiumn N-dodecyl-N,N-dimethylchloride and benzenethanaminiumn N-dodecyl-N,N-dimethyl-N-tetradecylchloride (2.33:1), S.0 % by volume of a mixture of benzyl-Cla-C16-alkyldimethyl-ammoniumchloride and 2-phenylphenol (2:1), 12.0 % by volume of 2-octyl-2H-isothiazol-3-one, 32.0 % by volume of a mixture=ot-' S-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:1), 1.0 % by volume of a,blend of polysiloxanes and balance by volume diethyleneglycol.
A further especially preferred anti-microbial composition comprises 6.0 1 s by volume of a mixture of benzenethanaminiumn N-dodecyl-N,N-dimethylchloride and benzenethanaminiumn N-dodecyl-N,N-dimethyl-N-tetradecylchloride (2.33:1), 6.0 % by volume of a mixture of benzyl-C~2-C16-alkyldimethyl-ammoniumchloride and 2-phenylphenol (2:1), 16.0 % by volume of 2-octyl-2H-isothiazol-3-one, 32.0 % by volume of a mixture of 2o S-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:1), 1.0 % by volume of a blend of poylsiloxanes and balance by volume isopropanol.
Yet another especially preferred anti-microbial composition comprises 6.0 2s % by volume of a mixture of benzenethanaminiumn N-dodecyl-N,N-dimethylchloride and benzenethanaminiumn N-dodecyl-N,N-dimethyl-N-tetradecylchloride (2.33:1), 6.0 % by volume of a mixture of benzyl-Cj2-C16-alkyldimethyl-ammoniumchloride and 2-phenylphenol (2:1), 16.0 % by volume of 2-octyl-2H-isothiazol-3-one, 32.0 % by volume of a mixture of 3o S-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one 1~

(3:1), 1.0 % by volume of a blend of polysiloxanes and balance by volume dipropyleneglycol.
According to a further aspect of the invention, there is provided a s formulation comprising an anti-microbial composition and at least one other functional material.
Suitable functional materials ~ include plastics, fibres, coatings, films, laminates, adhesives, sealants, clays, china, ceramics, concrete, sand, paints, 1o varnishes, lacquers, cleaning agents or settable or curable compositions such as fillers, grouts, mastics and putties.
The plastics may be in the form of films, sheets, stabs and molded plastic parts. Suitable plastics materials may be prepared from polyesters such as is polyethylene terephthalate, polybutylene terephthalate, polyamides such as Nylon, polyimides, polypropylene, polyethylene, polybutylenes, polymethylpentene, polysiloxane, polyvinyl alcohol, polyvinylacetate, ethylene-vinylacetate, polyvinyl chloride, polyvinylidene chloride, epoxy, phenolic and polycarbonate cellulosics, cellulose acetate, polystyrene, 2o polyurethane, acrylics, polymethyl methacrylate, acrylonitrile, butadiene-styrene copolymer, acrylonitrilestyrene-acrylic copolymers, acetals, polyketones, polyphenylene ether, polyphenylene sulf de, polyphenylene oxide, polysulfones, liquid crystal polymers and fluoropolymers, amino resins, thermo plastics, elastomers, rubbers such as styrene butadiene rubber 2s and acrylonitrile butadiene rubber, polyacetal (polyoxymethylene), and blends and copolymers thereof.
Formulations comprising the anti-microbial composition and a plastics material as the functional material may, for example, be used to form 3o products such as automobile parts, shower curtains, mats, protective covers, tape, packaging, gaskets, waste containers, general purpose containers, brush handles, sponges, mops, vacuum cleaner bags, insulators, plastic film, indoor and outdoor furniture, tubing, insulation for wire and cable, plumbing supplies and fixtures, siding for housing, liners, non-woven fabrics, kitchen and bathroom hardware, appliances and equipment, countertops, sinks, flooring, floor covering, tiles, dishes, conveyer belts, footwear including boots, sports equipment and tools.
Suitable fibres may be prepared from acetate, polyester such as PET and 1o PTT, polyolefins, polyethylene, polypropylene, polyamides such as Nylon, acrylics, viscose, polyurethane, and Rayon, polyvinyl alcohol, polyvinyl chloride, polyvinylidene chloride, polysaccharide, and copolymers and blends thereof.
~s Formulations comprising the anti-microbial composition and a fibre as the functional material may, for example, be used in applications such as mattress cover pads and filling, pillow covers, sheets, blankets, fiberfill for quilts and pillows, curtains, draperies, carpet and carpet underlay, rugs, upholstery, table cloths, napkins, wiping cloths, mops, towels, bags, wall 2o covering fabrics, cushion pads, sleeping bags and brush bristles. The fibres are also suitable for use in automotive and truck upholstery, carpeting, rear decks, trunk liners, convertible tops and interior liners. Furthermore, the fibres are suitable for use in umbrellas, outerwear, uniforms, coats, aprons, sportswear, sleepwear, stockings, socks, hosiery caps, and undergarment 2s and inner liners for jackets, shoes, gloves and helmets, trim for outerwear and undergarments as well as brush bristles, artificial leather, filters, book covers, mops, cloth for sails, ropes, tents, and other outdoor equipment, tarps and awnings.
3o Coatings suitable for use in the formulations include water-borne, solvent-borne, 100% solids and/or radiation cure coatings. The coatings may be liquid or powder coatings.
Suitable coatings, films and laminates include alkyds, amino resins, such as s melamine formaldehyde and urea formaldehyde, polyesters, such as unsaturated polyester, PET, PBT, polyamides such as Nylon, polyimides, polypropylene, polyvinylacetate, ethylene-vinylacetate, polyvinyl chloride, polyvinylidene chloride, epoxy, phenolic and polycarbonate cellulosics, cellulose acetate, polystyrene, polyurethane, acrylics, polymethyl 1o methacrylate, acrylonitrile-butadiene-styrene copolymer, acrylonitrile-styreneacrylic copolymers, acetals, polyketones, polyphenylene ether, polyphenylene sulfide, polyphenylene oxide, polysulfones, liquid crystal polymers and fluoropolymers, thermoplastic elastomers, rubbers such as styrene butadiene rubber, acrylonitrile ' butadiene rubber, polyacetal 15 (polyoxymethylene), and blends and copolymers thereof.
Formulations comprising the anti-microbial composition and coatings as the functional material may, for example, be used on walls, wall boards, floors, concrete, sidings, roofing shingle, industrial equipment, natural and 2o synthetic fibres and fabrics, furniture, automotive and vehicular parts, packaging, paper products (wall coverings, towels, book covers) barrier fabrics, and glazing for cement tile and fox vitreous china used in plumbing fixtures such as toilets, sinks, and countertops.
2s Adhesives and sealants suitable for use in the formulations include hot-melt, aqueous, solvent borne, 100% solids and radiation cure adhesives and sealants.
Suitable adhesives and sealants include alkyds, amino resins such as 3o melamine formaldehyde and urea formaldehyde, polyesters such as unsaturated polyester, PET, PBT, polyamides such as Nylon, polyimide polypropylene, polyethylene, polybutylene, polymethylpentene, polysiloxane, polyvinyl alcohol, polyvinylacetate, ethylene-vinylacetate, polyvinyl chlorides such as plastisol, polyvinylidene chloride, epoxy, phenol and polycarbonate, cellulosics, cellulose acetate, polystyrene, polyurethane, acrylics, polymethylmethacrylate, acrylonitrile-butadienestyrene copolymer, acrylonitrile-styrene-acrylic copolymers, acetals, polyketones, polyphenylene ether, polyphenylene sulfide, polyphenylene oxide, polysulfones, liquid crystal polymers and fluoropolymers, thermoplastic elastomers, rubbers (including styrene butadiene rubber, acrylonitrile butadiene rubber, CR), polyacetal (polyoxymethylene), and blends and copolymers thereof.
Formulations comprising the anti-microbial composition and an adhesive or 1s sealant as the functional material may, for example, be used in the manufacture of wood and plastic composites, adhesives for ceramic tiles, wood, paper, cardboard, rubber and plastic, glazing for windows, grout, sealants for pipes, adhesives, sealants and insulating materials for appliances, bathrooms, showers, kitchens, and construction.
Formulations comprising the anti-microbial composition and clay, china, ceramics, concrete, sand or grout as the functional material may, for example, be used in toilets, sinks, tile, flooring, stucco, plaster, cat litter, drainage and sewerage pipe.
as The anti-microbial composition can be combined into a very wide variety of functional compounds for the manufacturing, contracting and construction industries. The nature of the anti-microbial composition may be varied according to the particular functional compounds and the number and nature of microorganisms present in the particular functional compound or environment in which it is used.
The formulation preferably comprises from 0.1 wt% to 5.0 wt%, more preferably from 0.1 to 4.0 wt%, even more preferably from 0.5 wt% to 2.0 wt%, of the anti-microbial composition.
The anti-microbial composition is highly effective against a broad range of microorganisms even when it is combined with another functional material to provide the formulation of the invention. The formulation can, optionally, be applied to a surface. The formulation provides long-term anti-microbial action, in both dry and damp conditions at the surfaces treated or in which the material is combined. This will lead to a sanitisation of the surfaces so that the surfaces and products will prevent the rapid replication of microbial species and, thus, substantially reduce the risks of 1s contamination and infection.
The anti-microbial composition is mobile through most functional materials in which it is incorporated in the formulations of the invention. This is due to the presence of surfactant materials and oils and molecules of short chain 20 length. In order to maintain this mobility, the surfactant materials and oils preferably have a carbon chain length of no greater than 20.
'The anti-microbial composition tends to migrate across a concentration gradient and moves to the surface of products into which it has been 25 incorporated. This is similar to the behaviour of plasticiser in polymers.
Both the anti-microbial composition and the formulation typically begin to dissociate into their component parts when they have been in continuous contact with water for longer than six to eight hours. The anti-microbial 3o action, of the anti-microbial composition and the formulation, is substantially reduced once the composition and formulation have dissociated into their component parts. The components can then act as a carbon source or nutrient for many species of microorganisms. Thus, the anti-microbial composition and the formulation can degrade when submersed in water, to provide a rinsate/leachate of low toxicity and which has a short residence time in the environment.
It is thought that the rinsates have a low toxicity because the anti-microbial agents are associated with the second compound and so the composition 1o does not readily dissociate in the presence of water.
The formulation can be designed so that it is stable and effective in most manufacturing environments. The formulation is typically stable up to temperatures of 200°C.
The property of mobility of the product permits materials that are highly frequently washed or rinsed to be "recharged" with the anti-microbial composition during a routine act of cleaning or maintenance.
2o Typically, the anti-microbial composition is incorporated into a simple conventional detergent solution or added to a "final rinse" during cleaning.
The anti-microbial composition will be drawn, due to the presence of its hydrophobic elements, into the surface of the product to be "recharged".
The sanitization properties of the formulation are, therefore, restored without the need for re-manufacture or difficult treatment processes.
Any wash off or rinsates containing the anti-microbial composition or formulation diluted by such a re-charging solution and water would quickly dissociate into the biodegradable components as previously discussed.

According to a further aspect of the invention, there is provided the use of an anti-microbial composition to prevent the formation of colonies of microorganisms on a surface at which it is provided.
s According to yet a further aspect of the invention, there is provided the use of a formulation to prevent the formation of colonies of microorganisms on a surface at which it is provided.
The anti-microbial composition and formulation have an anti-bacterial 1o effect against a wide range of gram-positive and gram-negative bacteria.
For example, they are effective against the following:
Bacillus species, such as Bacillus subtilis, Bacillus cereus Is Brevibacterium species Brucella species, such as Brucella abortus Lactobacillus species Proteus vulgaris Pseudomonas aeruginosa 2o Salmonella species Staphylococcus species, such as Methicillin Resistive Staphylococcus Aureus (MRSA) Streptococcus species Flavobacterium species 2s Escherichia species Aeromonas species The anti-microbial composition and formulation also have activity against fungi and yeasts, such as:

Penicillium species Aspergillus niger Cladosporium species Fusarium species s Paecilomyces species Streptomyces species Saccharomyces species, such as S.cerevisiae Monilia albicans to The anti-microbial composition and formulation also have activity against certain species of algae such as:
Chlorella pyrenoidosa Pleurococcus 15 Anabaena species According to another aspect of the invention, there is provided a method of manufacturing an anti-microbial composition, the method comprising the steps of (i) mixing the first compound and the first anti-microbial agent 2o together, (ii) adding the second compound to the mixture of first compound and the first anti-microbial agent, (iii) adding the polar solvent to the mixture of the first and second compounds and the first anti-microbial agent and (iv) agitating the resulting mixture until a clear solution is formed.
2s According to yet a further aspect of the invention, there is provided a method of manufacturing a formulation, the method comprising the step of adding the anti-microbial composition to the functional compound.
The present invention is now illustrated but not limited with reference to the 3o following examples.

Example 1 Preparation of Anti-microbial Composition ("D4L") A composition according to the present invention comprising components (a) to (f) in the amounts indicated was prepared:
s (a) 32.0% by volume of a mixture of two benzalkonium chlorides (in a ratio of 2.33:1) i.e. benzenethanaminiurnn N-dodecyl-N,N-dimethylchloride and benzenethanaminiumn N-dodecyl-N,N-dimethyl-N-tetradecyl-chloride (Trade Name: BAC-SOm);
(b) 6.0% by volume of a mixture of benzyl-C12-C16-alkyldimethyl-ammoniumchloride (CAS no. 68424-85-1) and 2-phenyl phenol in the ratio 2:1 (Trade Name: Acticide 50X);
1s (c) 6.0% by volume of 2-octyl-2H-isothiazol-3-one (Trade Name: A-DVt~;
(d) 16.0% by volume of a mixture of 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H isothiazol-3-one in the ratio 3:1 (Trade Name: A-14);
20 (e) 1.0% by volume of polydimethylhydroxysiloxane (Trade Name: PD-D);
and (f) 39% by volume of an isopropanol blend (isopropanol, n-propanol and water to azeotropic limit about 1.0 %).
Anti-microbial agents a, b, c and d were mixed together sequentially at room temperature following the sequence described above. The resulting mixture was then agitated thoroughly and the polysiloxane (e) was added to the mixture. The resulting mixture was agitated and isopropanol (f) was 3o added. The mixture was then agitated until a clear solution was obtained.

The clear solution is referred to herein as "D4L".
Example 2 Preparation of Anti-Microbial Composition ("LCF") s A composition according to the present invention comprising components (a) to (f) in the amounts indicated was prepared:
(a) 32.0% by volume of a mixture of two benzalkonium chlorides (in a ratio of 2.33:1) i.e. benzenethanaminiumn N-dodecyl-N,N-dimethylchloride and benzenethanaminiumn N-dodecyl-N,N-dimethyl-N-tetradecyl-chloride (Trade Name: BAC-SOm);
(b) 6.0% by volume of a mixture of benzyl-Ci2-C~6-alkyldimethyl-is ammoniumchloride (CAS no. 68424-85-1) and 2-phenyl phenol in the ratio 2:1 (Trade Name: Acticide 50X);
(c) 6.0% by volume of 2-phenyl phenol;
(d) 16.0% by volume of a 25% solution of 1,2-benziothiazolin-3-one in isopropanol;
(e) 1.0% by volume of polydimethylhydroxysiloxane (Trade Name: PD-D);
and 2s (f) 39% by volume of an isopropanol blend (isopropanol, n-propanol and water to azeotropic limit about 1.0 %).
Anti-microbial agents a, b, c and d were mixed together sequentially at 3o room temperature following the sequence described above. The resulting mixture was then agitated thoroughly and the polydimethylhydroxysiloxane (e) was added to the mixture. The resulting mixture was agitated and isopropanol (f) was added. The mixture was then agitated until a clear solution was obtained. The clear solution is referred to herein as "LCF".
s Example 3 Preparation of Detergent Formulation comprising the Anti-microbial Agent Composition of Example 1 (i.e. D4L) 1o An amphoteric non-ionic detergent, such as washing-up liquid, having a pH
of from 6 to 8, was diluted in water in a ratio of 1 part detergent to 25 parts of water by volume. To this solution was added between 0.5 and 2.0 % by volume of the anti-microbial agent composition prepared according to Example 1 (i.e. D4L).
is Example 4 Effectiveness of Anti-microbial Agent Formulation against Escherichia coli, Staphylococcus aureus and Pseudomonas aerugmosa.
Method Two samples were tested. These were a detergent formulation prepared according to Example 3 comprising 2% by volume of the anti-microbial 2s agent composition of Example l, and a neutral detergent. The neutral detergent was used as a standard reference.
A bacterial culture (0.1 mI) in a nutrient medium was applied to a previously sterilised petri dish over an area 7 x 5 cm. The bacterial culture 3o was then allowed to dry for 30 minutes.

The inoculated area was then wiped with a test wipe soaked either in water or the test solution to contact the test fluid with the bacteria. The test solution was applied using either an absorbent cloth or an innoculum loop.
The innoculated area was also left untreated to provide an "uncleaned s control", in which the infected area was not washed or even wiped with water. The bacteria remaining on the surface of the petri dish were numerated after periods of 15 and 30 seconds.
The bacteria remaining on the surface of the petri dish were numerated by 1o wetting a sterile swab in a sterile peptone solution (0.1%) and thoroughly rubbing the swab over the area to be sampled, turning the swab as it was rubbed over the appropriate area. The swab was then returned to a sterile tube; Ringers solution (5 ml, 1l4 strength) was added; and the swab left for at least 10 minutes.
is The swab tubes were plated out making serial decimal dilutions, using the Miles and Misra Total Viable Count Technique and incubated inverted at 37°C overnight. The number of colony forming units (CFU) (taken to be viable bacterial individuals) was then counted.
Calculation The log reduction in bacterial numbers was calculated compared to the water control and the uncleaned control.
2s The total number of CFUs per ml of neat sample was calculated for each test sample and the controls.
The log of the number of CFUs for the water control, or the uncleaned 3o control, was calculated to give value A. This was repeated for the test anti-microbial composition to give value B.
A-B = Log Reduction (A = log CFUs water or uncleaned control, B = log CFUS test sample) s A Iog reduction of greater than 4 is considered to be effective.
Table 1 - Results Composition Organism Log reduction Log reduction after 15 sees after 30 sees Anti-microbial Esclaerichia 1.0 >4.0 colt composition Anti-microbial Staphylococcus>4.9 >4.9 composition aureusb Anti-microbial Pseudomonas 1.~ 3.3 composition aeruginosa' a 1 uiai viaoie count o.a x t v b Total viable count 5.8 x 108 c Total viable count 1.5 x 109 Conclusions is A 2% by volume solution of the anti-microbial composition gave a Iog reduction of 1.0 after 15 seconds and >4.0 after 30 seconds when tested against Escherichia colt.
A 2% by volume solution of anti-microbial composition gave a log 2o reduction of >4.9 after 15 seconds when tested against Staphylococcus aureus.
A 2% by volume solution of anti-microbial composition gave a log reduction of 1,~ after 15 seconds and 3.3 after 30 seconds when tested against Pseudomonas aeruginosa.
Example 5 Resistance of Painted Film Formulations containing an Anti-microbial Composition to Dry Film Fungal and Algal Colonisation The following formulations comprising paint and the anti-microbial agent 1o composition of Example 1 were tested:
Composition Number % by volume of Anti-microbial Composition Control 0.00%

1 0.50%

2 0.75%

3 1.00%

4 1.50%

5 2.00%

Method - Dry Film Fungal Resistance Test (Based on British Standard BS3900 Part G6) ~s Each formulation was painted onto 6 x 9 cm gypsum panels. Two coats of each formulation were painted onto the gypsum panels, allowing 24 hours drying time between each coat. When the panels were dry, they were spray inoculated with a mixed spore suspension prepared from fungi (including 2o yeasts) isolated from or known to grow on painted surfaces. The test panels were suspended in a high humidity cabinet at 24°C for four weeks and the resultant fungal growth assessed visually and microscopically. Fungal growth rating was according to BS3900 Part G6.
The micro-organisms used were: Aspergillus versicolor Aureobasidium pullulans s Cladosporium cladosporioides Penicillium purpurogenum Phoma violaceae Rhodotorula rubra Sporobolomyces roseus Stachybotrys chartarum Ulocladium atrum Method - Dry Film Algal Resistance Test - Vermiculite Bed Method is Each formulation was painted onto 10 x 10 cm calcium silicate panels. Two coats of each formulation were painted onto the panels, allowing 24 hours drying time between each coat. When the panels were dry, they were weathered using a QUV Accelerated Weathering Tester for 125 hours using a water spray cycle. Each panel was then cut in half. The half panels were 2o placed in the surface of vermiculite (200 g) moistened with water (~00 cm3) in a transparent plastic box with a close fitting lid. The panels were each spray inoculated with a mixed algal suspension three times at intervals of two weeks and sprayed with water each week. The panels were incubated for 13 weeks at 20°C and illuminated with 30 W daylight type fluorescent 2s tubes (giving approximately 1000 lux) fox 16 hours per day. The resultant algal growth was assessed visually and microscopically.
The microorganisms used were: Chlorella emersonii Gloeocapsa alpicola 3o Nostoc commune Pleurococcus sp.
Stichococcus bacillaris Stigeoclonium tenue Trentepohlia aurea Trentepohlia odorata Results Table 2 - Dry Film Fungal Resistance Test Composition Number % Anti-microbial Observed Rating*
agent (4 weeks) (by volume) Control 0.00% 4 (40+) 1 0.50% 3 (30+) 2 0.75% 2 (10+) 3 1.00% 2 (5+) 4 1.50% 2 (5+) 2.00% 0 (0) .

*Average rating of replicate panels given.
Table 3 - Dry Film Algal Resistance Test Composition % Anti-microbialFilm Algal Rating/Intensity Number agent Growth - - Replicate (by volume) Replicate 1 2 Control 0.00% 4 (50+) 4 (40+) 1 0.50% 3 (20+) 3 (20+) 2 0.75% 2 (10+) 3 (15+) 3 1.00% 2 (10+) 2 (10+) 4 1.50% 2 (10+) 2 (10+) 5 2.00% 2 (S+) 2 (5+) Growth Ratings The first figure represents the fungal growth cover as follows:
s 0 = No growth 1 = Trace growth 2 = 1 to 10% Coverage of growth 3 = 11 to 30% Coverage of growth 4 = 31 to 70% Coverage of growth 5 = 71 to 100% Coverage of growth The second figure in brackets represents the % cover and an assessment of the intensity rating, as follows:
is 0 - Growth barely visible to the naked eye + - Light growth ++ - Moderate growth +++ - Dense growth 2o Conclusion The control sample (containing no anti-microbial composition) was found to be susceptible to dry film fungal and algal colonisation.
2s An addition of 1.0% of the anti-microbial composition was found to control the fungal and algal population to a level that meets the pass criterion, of below 20%.

Example 6 Microbiological Testing against MRSA of Coil Coating Panels Treated with the Anti-microbial Composition of Example 1 Coil coating panels, manufactured by Becker Industrial Coatings Ltd., Liverpool, were treated with a range of concentrations of an anti-microbial composition according to Example 1. The panels were then tested to demonstrate whether they have antibacterial properties against Methicillin Resistant Staphylococcus Aureus (MRSA).
The panels were coated as follows:
S1 Coil coating panel, 1.0% by volume anti-microbial composition S2 Coil coating panel, 1.5% by volume anti-microbial composition S3 Coil coating panel, 2.0% by volume anti-microbial composition S4 Coil coating panel, 2.5% by volume anti-microbial composition SS Coil coating panel, 3.0% by volume anti-microbial composition S6 Coil coating panel, 0% anti-microbial composition (control) 2o Method The MRSA culture was diluted to approximately 1.5 x 104 CFUImI with sterile deionised water. 1 ml of this solution was placed on a coil coating panel and was continuously applied over an area of approximately 5 cm x 5 2s cm using a hand held spreader for a contact period of 1 minute. The culture was immediately recovered from the panel using a swab and was transferred to a universal bottle containing neutralizer (1 ml) and maximum recovery diluent (9 ml). 10 fold serial dilutions were prepared and 0.1 ml aliquots of the dilutions were plated onto nutrient agar, in duplicate. The plates were 3o incubated at 37°C for 24 hours and 4~ hours and read using conventional techniques.
The procedure was repeated with a culture contact time of 5 minutes. All six samples were subjected to the same test protocol.
s Table 4 - Results Sample Contact time 1 min Contact time 5 min (CFU/ml) (CFU/ml) S6 1.1x10' 2.5x10' Conclusion 1o All of the test samples (S1 to SS) produced very significant decreases in the bacterial count (from I.5 x 103 CFU/ml) in 1 minute of contact time and further small decreases after 5 minutes. Total bacterial kill was not achieved in 5 minutes of contact.
1s The control sample (S6) produced a small decrease in the bacterial count (from 1.5 x I03 CFU/ml) in I minute of contact time, which may be primarily due to the diff culty of recovering the culture from the panels using swabbing techniques. After 5 minutes of contact time the control samples bacterial count had significantly decreased primarily due to the 2o drying out of the culture during the continuous spreading action on the panels.

The coil coatings treated with the anti-microbial composition are effective, at all of the tested concentrations, in very significantly reducing the level of MRSA bacteria when in contact in an aqueous medium for short periods.
s These coatings would be very effective in assisting in the control of MRSA
bacterial contamination in hospitals and similar environment.
Example 7 Microbiological Testing against MRSA of HMG's Panels of to Food Safe PVC 94 Laminate Treated with the Anti-microbial Composition of Example 1 Panels, from H. Marcel Guest Ltd (HMG), coated with food safe PVC 94 laminate were treated with a formulation comprising a paint and 2% by 1s volume of the anti-microbial composition prepared according to Example 1 in order to demonstrate whether they have antibacterial properties against Methicillin Resistant Staphylococcus Aureus (MRSA).
Samples Sl PVC 94 laminated panel, 2% by volume anti-microbial composition, Clear.
S2 Control, Clear.
S3 PVC 94 laminated panel, 2% by volume anti-microbial composition, 2s White.
S4 Control, White.
Method 3o The MRSA culture was diluted to approximately 1.5 x 104 CFU/ml with sterile deionised water and 1 ml was placed on a panel and continuously applied over an area of approximately 5 cm x 5 cm using a hand held spreader for a contact period of 1 minute. The culture was immediately recovered from the panel using a swab and was transferred to a universal bottle containing neutralizer (1 ml) and maximum recovery diluent (9 ml).
fold serial dilutions were prepared and 0.1 ml aliquots of the dilutions were plated onto nutrient agar, in duplicate. The plates were incubated at 37°C for 24 hours and 48 hours and read using conventional techniques.
The procedure was then repeated with a culture contact time of 5 minutes.
1o All four samples were subjected to the same test protocol.
Table 5 - Results Sample Contact Time 1 min Contact Time 5 min (CFU/ml) (CFU/ml) Sl 52 30 S2 2.1 x 102 1.6 x 102 S4 ~ 4.1 x 102 ~ 1.9 x 102 Discussion 1s The test samples (S 1 and S3) produced very significant decreases in the bacterial count (from 1.5 x 103 CFU/ml) in 1 minute of contact time and further small decreases after 5 minutes. Total bacterial kill was not achieved in 5 minutes of contact.
The control samples (S2 and S4) produced significant but smaller decreases in the bacterial count (from 1.5 x 103 CFU/ml) in 1 minute and 5 minutes of contact time. This may be partially due to the difficulty of recovering the culture from the panels using swabbing techniques and to the drying out of the culture during the continuous spreading action on the panels.
Conclusions The PVC 94 laminated panels treated with 2% by volume anti-microbial composition are effective in reducing the level of MRSA bacteria when in contact in an aqueous medium for short periods.
These coatings would be likely to be very effective in assisting in the to control of MRSA bacterial contamination in hospitals and similar environment.
Example 8 Determination of the Anti-microbial Effect of Coated Test is Panels Containing the Anti-microbial Composition according to Example 1 The microorganisms tested were:
2o Bacillus subtilis NCTC 44878 3.2 x 106 CFU/ml Pseudomonas aeruginosa NCTC 10662 3.6 x 106 CFU/ml Method 25 Test panels were coated with paint/powder coatings containing the anti-microbial composition according to Example 1. The coated test panels were challenged with broth cultures of the two organisms at the above concentrations for 10 minutes contact time.
3o The bacterial suspension was pipetted onto the coated test panel and removed with a swab after 10 minutes. The swab was transferred to maximum recovery diluent and plated onto Standard Plate Count Agar, incubated at 30°C for 24 hours and the total number of colonies counted.
s Results Table 6 - Paint Coating Panel Number Bacillus subtilis Pseudomonas (CFU/ml) aeruginosa (CFUIml) Table 7 - Epoxy Polygloss Powder Coating Panel Number Bacillus subtilis Pseudomonas (CFU/ml) aeruginosa (CFU/ml) to Table 8 - Grey Epoxy Polyester Gloss Powder Coating Panel Number Bacillus subtilis Pseudomonas (CFU/ml) aeruginosa (CFU/ml) TNC TNC

'1'NC; ='1'0o numerous to count Conclusion s The results show that the bacteria are almost completely eradicated within minutes contact time by the anti-microbial composition according to Example I in many of the paint/powder coating formulations, even though the surface is dry.
A powder coating containing the anti-microbial composition according to Example 1 at the concentrations shown to be effective is, therefore, likely to be highly effective in reducing the number of bacteria on a surface in a short timescale.
~s Example 9 Effectiveness of the Anti-microbial Composition "LCF" of Example 2 2o The samples tested were as follows:
1000 LCF: 1% by volume LCF in water 2000 LCF: 2% by volume LCF in water 3000 LCF: 3% by volume LCF in water The microorganisms used were:
Legionella pneumophila NCTC 11192 s Escherichia coli NCTC9001 Staphylococcus aureus NCIMB 12702 Salmonella enteritidis NCTC5188 Listeria monocytogenes Type 1 NCTC7973 Pseudomonas aeruginosa NCIMB 12469 Method The European Suspension Test (Pr En 1276 November 1995) was conducted under the following experimental conditions:
Is Test concentrations: Neat Test temperature: 10°C (+/- 1 °C) Test conditions: Clean (0.3g/100m1 bovine albumin) Dirty (3g/100m1 bovine albumin) 2o Neutraliser: Lecithin 3g/1, polysorbate 80 30g/1, sodium thiosulphate Sg/l, L. histidine Ig/l, saponin 30g/I
in diluent Contact time: 5 min Temp of incubation: 37°C (+/- 1 °C) as Results For the test results to be valid the neutraliser used must be shown to be non-toxic to the bacteria and to adequately neutralise the product under test. The 3o experimental test conditions must also be validated.

To pass the test the product when diluted in hard water must demonstrate at least a 105 reduction in viable count when tested under simulated clean or dirty conditions and under the required test conditions.
Table 9 - Results for 1000 LCF
Test Organisms Clean ConditionsPass/FailDirty ConditionsPass/Fai Log Reduction Log Reduction L. pneumophila 4.12 FAIL ~ 3.94 FAIL

E. coli 4.26 FAIL 4.02 FAIL

S. aureus 4.08 FAIL 4.10 FAIL

S. enteritidis 4.44 FAIL 4.08 FAIL

L. monocytogenes4.54 FAIL 4.20 FAIL

P. aeruginosa 4.02 FAIL 3.90 FAIL

Table 10 - Results For 2000 LCF
Test Organisms Clean ConditionsPass/FailDirty ConditionsPasslFai Log Reduction Log Reduction L. pneumophila 4.68 FAIL 4.62 FAIL

E. coli 4.76 FAIL 4.34 FAIL

S. aureus 4.68 FAIL 4.22 FAIL

S. enteritidis 4.72 FAIL 4.28 FAIL

L. monocytogenes4.86 FAIL 4.30 FAIL

P. aeruginosa 4.64 FAIL 4.10 FAIL

to Table 11- Results for 3000 LCF
Test Organisms Clean ConditionsPass/FailDirty ConditionsPass/Fai Log Reduction Log Reduction L. pneumophila 4.84 FAIL 4.b8 FAIL

E. coli 4.72 FAIL 4.27 FAIL

S. aureus 4.84 FAIL 4.44 FAIL

S. enteritidis 4.92 FAIL 4.95 FAIL

L. monocytogenes4.98 FAIL 4.54 FAIL

P. aeruginosa 4.79 FAIL 4.62 FAIL

Conclusion s All three samples, 1000 LCF, 2000 LCF and 3000 LCF, failed the European Suspension Test at 10°C for all of the microorganisms used.
However, although the samples failed this stringent test, they did display significant anti microbial activity against all of the organisms.
to Example 10 Effectiveness of the Anti-microbial Composition "D4L" of Example 1 The samples tested were as follows:
500 D4L: 0.5% by volume D4L in water 1000 D4L: 1.0% by volume D4L in water 1500 D4L: 1.5% by volume D4L in water 2000 D4L: 2.0% by volume D4L in water The microorganisms used were:
Legionella pneumophila NCTC 11192 Escherichia coli NCTC9001 Staphylococcus aureus NCIMB 12702 Salmonella enteritidis NCTC5188 Listeria monocytogenes Type 1 NCTC7973 s Pseudomonas aeruginosa NCIMB 12469 Method The European Suspension Test was conducted under the following experimental conditions:
to Test concentrations: Neat Test temperature: 10°C (+/- 1 °C) Test conditions: Clean (0.3g1100m1 bovine albumin) Dirty (3g/100m1 bovine albumin) 1s Neutraliser: Lecithin 3g/1, polysorbate 80 30g/1, sodium thiosulphate Sg/1, L. histidine 1g/1, saponin 30g/1 in diluent Contact time: 5 min Temp of incubation: 37°C (+/- 1 °C) Results For the test results to be valid the neutraliser used must be shown to be non-toxic to the bacteria and to adequately neutralise the product under test. The experimental test conditions must also be validated.
To pass the test the product when diluted in hard water must demonstrate at least a 105 reduction in viable count when tested under simulated clean or dirty conditions and under the required test conditions.

Table 12 - Results for 500 D4L
Test Organisms Clean ConditionsPass/Fail Dirty ConditionsPass/Fai Log Reduction Log Reduction L. pneumophila 4.64 FAIL 4.48 FAIL

E. coli 4.76 FAIL 4.55 FAIL

S. aureus 4.80 FAIL 4.70 FAIL

S. enteritidis 4.82 FAIL 4.75 FAIL

L. monocytogenes4.89 FAIL 4.72 FAIL

P. aeruginosa 4.50 FAIL 4.36 - ~ FAIL

Table 13 - Results for 1000 D4L
Test Organisms Clean ConditionsPass/FailDirty ConditionsPass/Fai Log Reduction Log Reduction L. pneumophila 6.10 PASS 5.64 PASS

E. coli 6.42 PASS 5.X5 PASS

S. aureus 6.10 PASS 5.58 PASS

S. enteritidis 5.98 PASS 5.92 PASS

L. monocytogenes6.72 PASS 6.27 PASS

P. aeruginosa 5.88 PASS 5.21 ~ PASS

Table 14 - Results for 1500 D4L
Test Organisms Clean ConditionsPass/Fail Dirty ConditionsPass/Fai Log Reduction Log Reduction L. pneumophila 6.88 PASS 6.14 PASS

E. coli 7.14 PASS 7.02 PASS

S. aureus 6.98 PASS 6.34 PASS

S. enteritidis 6.52 PASS 6.40 PASS

L. monocytogenes7.39 PASS 6.83 PASS

P. aeruginosa 6.45 PASS 6.06 - ~ PASS

Table 1 S - Results for 2000 D4L
Test Organisms Clean ConditionsPasslFail Dirty ConditionsPass/Fai Log Reduction Log Reduction L. pneumophila 7.22 PASS 6.48 PASS

E. coli 7.20 PASS 7.12 PASS

S. aureus 7.34 PASS 7.08 PASS

S. enteritidis 7.12 PASS 6.62 PASS

L. monocytogenes7.59 PASS 7.36 PASS

P. aeruginosa 6.78 PASS 6.32 PASS

s Conclusion Three samples, 1000 D4L, 1500 D4L and 2000 D4L, passed the European Suspension Test at 10°C, for all of the microorganisms under test.
Under 1o identical conditions 500 D4L failed the test.
A comparison of the results of the tests of Examples 9 and 10 shows that the composition "D4L" is more effective than the composition "LCF". The composition "D4L" includes anti-microbial agents that are more polar than those included in the composition "LCF". Thus, the inclusion of polar anti-microbial agents increases the efficacy of the composition.
Example 12 The dissociation of the Anti-microbial Composition "D4L" of Example 1 upon immersion in water This Example was conducted to assess the difference in biofilm growth between experimental and control surfaces after 48 hours submersion in 1o water. The experimental surfaces were coated with the anti-microbial composition but the control surfaces were not.
Method Eight aluminium bottles were painted with four different paint types. The paint types were Series 1 to 4, as set out below. Four of the bottles were painted with paint including 2% by weight of the anti-microbial composition of Example 1 and four were painted with standard paint and used as controls.
The paint types were as follows:
Series l: ~ I~ Type Gloss (tough, durable enamel for high quality industrial finishing and decorative interior/exterior 2s woods).
Series 2: Matt White Emulsion (interior/exterior decorative duties. Contains a preservative for in can protection against microbial spoilage).

Series 3: Blue Hydracoat (waterborne alternative to alkyd synthetic enamels used for toy and model coating).
Series 4: Aquaguard (two pack epoxy coatings for walls and floors).
Each bottle was placed into an inoculated solution, covered and incubated for 48 hours. The bottles were then removed and sprayed with 0.5%
Tween/phosphate buffer solution (100 ml) to remove any biofilm that had formed. The resulting solutions were plated out making serial decimal to dilutions, using the Miles and Misra Total Viable Count Technique and incubated inverted at 37°C overnight. The number of colony forming units (CFI (taken to be viable bacterial individuals) was then counted and the experimental plates were compared to the controls.
1 s Results Biofilm growth recovered after 24 hours - E. coli Series 1: 50% more growth on experimental, compared to the control.
2o Series 2: No growth on experimental, very small growth on control.
Series 3: 25% more growth on experimental, compared to control.
Series 4: 43% more growth on experimental, compared to the control.
Biofilm growth recovered after 24 hours - Pseudomonas aeruginosa as Series 50% more growth on experimental, compared 1: to the control.

Series No growth on control, very small growth on 2: experimental.

Series 25% more growth on experimental, compared 3: to control.

Series 4: 20% more growth on experimental, compared to the control.

Conclusion The components of the anti-microbial compositions dissociate and dissolve in the surrounding solution and provide a carbon source for the microbial populations. The results show an increase in growth of microorganisms on the treated materials after 24 hour immersion in microbial broth. This indicates a more nutrient rich environment in the paints including the anti-microbial composition of the invention compared to the controls and shows that the anti-microbial composition is biodegradable.
Example 13 Low Rinsate Toxicology Method ~s Four different surface coatings, paint series 1 to 4 as described in Example 12, were applied to aluminium panel substrates. These were then compared to controls that did not include the anti-microbial composition.
2o The microorganisms used were E. coli and Pseudomonas aerogenosa.
After 24 hours, the panels were rinsed with deionised water and the washings tested using Microtox Testing. This test uses a photoluminescent vibrio sp. (a bioluminous microbe) that is highly responsive to the effect of 2s toxins. In the Microtox Test, a sample is mixed with living bacteria that are sensitive to the presence of toxic compounds. The mixture is allowed to regulate for a short time and then a light reading is taken. In the presence of substances at concentrations that are acutely toxic and which pose harm to humans, the bacteria are impaired and cease to give off light. Thus, the 3o greater the light loss from a sample, the more toxic it is.

Results Figures 1 and 2 show the residual P. aeruginosa and E. coli biof lm recovered after 24 hours, for the experimental and control samples s respectively. It is clear from Figures 1 and 2 that the biofilm formation is greater for the control samples.
Figures 3 and 4 show the toxicity of the surface rinsates for P. aeruginosa and E. coli, for the experimental and control samples respectively. Rinsates to for the control samples are less toxic than for the experimental samples.
However, the rinsates for both the experimental and the control samples showed low toxicity.
Values for the effective concentration at which 50% of the population is suffers from some adverse effect (EC50) were difficult to calculate and values for the lethal dose 50 (LD50) were not calculable.
The rinsate of some of the anti-microbial compositions was similar in effect to that of the control of other test paints. For example, paint series 1 2o including the anti-microbial composition had similar effect on the test as paint series 3 without the composition of the invention. Thus, different products of similar types (i.e. paints) have different results in the Microtox test on the rinsate. This indicates that the anti-microbial composition of the invention only has a small effect on the rinsate toxicology, which is within 2s the normal range for products that do not include anti-microbial agents.
Thus, the rinsate has low toxicity and is safe.
Low toxicity of rinsates from the compositions of the invention is highly desirable for the environment.

Example 14 Anti-microbial Testing of Coated Panels Steel panels. with a coating containing 0% (as a control), 1.5%, 2.0% and 3.0% by volume of the anti-microbial composition of Example 1 were tested.
The microorganisms used were:
Methicillin resistant staph aureus (MRSA) NCTC11940/2.1x105CFU/ml to Pseudomonas aeruginosa NCIMB12469/2.9x105 CFU/ml Eschericia coli NCTC9001/2.2x105 CFU/ml Method The selected microorganism (0.1 mI) was transferred to each of the coated panels. A sheet of sterile plastic (S cm x S cm) was placed onto the microorganism, which was then carefully spread to fill the area covered by the plastic film.
2o The frst set of samples was processed immediately on completion of the above procedure, i.e. at 0 min.
The plastic film was removed and placed onto a ceramic tile, ensuring that the surface that had been in contact with the contaminated plate was 2s uppermost. The exposed surface was then swabbed to remove all traces of the microorganism and the swab was transferred to 10 ml of maximum recovery diluent (MRD). A . second swab was used to swab the contaminated area on the surface of the panel. This swab was also transferred to the same vial of MRD and the vial was allowed to stand for min to ensure that the swabs were well soaked. The vial was then whirlimixed thoroughly for 10 seconds.
The resulting mixture (0.1 ml) was then transferred onto nutrient agar plates s and the plates were incubated at 37°C for 48 hours.
The procedure was repeated on a further two sets of samples after a 30 min and I6 hour contact period at 25°C.
1 o Results The results of the tests undertaken on the coated panels are detailed in Table 16, 17 and 18. The results in Table 16 should be read as the base data with which the results obtained after 30 min and 16 hours are compared.
is However, it is clear from the variation is the results that recovery of the contaminating organisms is not entirely consistent.
Table 16 - Time 0 min (counts per plate) Sample 1.5% 2.0% 3.0% Control E. coli 105 98 118 142 P. aeruginosa103 100 139 115 Table 17 - Time 30 min (counts per plate) Sample 1.5% 2.0% 3.0% Control E. coli 7 0 1 91 P. aeruginosa18 4 S 103 Table 18 - Time 16 hours (counts per plate) Sample 1.5% 2.0% 3.0% Control E. coli 0 0 0 39 P. aeruginosa0 0 0 79 s Conclusion The results in Table 17 show that, even after 30 minutes contact, the antibacterial effect of the anti-microbial composition is evident. The consistently higher counts obtained from the control panel support this. In 1o addition, there is a significant difference between the counts from the test panel containing 1.5% by volume of the anti-microbial composition and from the test panels containing 2.0% and 3.0% by volume of the anti-microbial composition, again supporting the antibacterial effect of the composition of the invention.
The counts detailed in Table I8 after 16 hours contact also endorse the antibacterial effect of the anti-microbial composition although the consistently lower control figures suggest that there may have been a drying out effect during incubation.
The results demonstrate that the anti-microbial composition of the invention confers an antibacterial effect on the panel coatings, giving the most effective kill at an inclusion rate 2.0% by volume or greater.

Claims (28)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. An anti-microbial composition consisting essentially of:

(i) at least one first anti-microbial agent having a surface tension of from 20 to 35 mN/m at 20°C and selected from (a) a quaternary ammonium compound having the general formula R1R2R3R4N+X- in which one or two of the R groups are alkyl substituted by aryl or interrupted by aryl or oxygen and the other R groups are the same or different and are C1 to C4 alkyl groups, (b) a dialkyldimethylammonium compound wherein the two non-methyl alkyl groups are selected from alkyl groups comprising from 8 to 12 carbon atoms, and (c) a benzalkonium halide or an aryl ring substituted benzalkonium halide;

(ii) at least one compound which is a siloxane and has a surface tension of from 8 to 14 mN/m at 20°C;

(iii) at least one polar solvent; and (iv) at least one additional anti-microbial agent;

wherein in use the anti-microbial composition acts substantially to reduce or control the formation of microbial colonies on or at a surface to which the composition is applied.
2. An anti-microbial composition according to claim 1, wherein the surface tension of the at least one compound (ii) is 10 mN/m.
3. An anti-microbial composition according to claim 1 or 2, wherein the at least one compound (ii) is at least one polysiloxane.
4. An anti-microbial composition according to claim 3, wherein the or each polysiloxane is selected from the group consisting of polydimethylsiloxanes, and polydimethylhydroxysiloxanes.
5. An anti-microbial composition according to claim 4, wherein the or each polysiloxane is selected from polydimethylsiloxanes having a chain length of from C12 to C20 and polydimethylhydroxysiloxanes having a chain length of from C12 to C20.
6. An anti-microbial composition according to any one of claims 1 to 5, wherein the at least one first anti-microbial agent and/or the at least one additional anti-microbial agent is of a polar nature.
7. An anti-microbial composition according to any one of claims 1 to 6, comprising at least one anti-microbial agent selected from the group consisting of bacteriocidal, fungicidal, algicidal, yeasticidal and moldicidal agents.
8. An anti-microbial composition according to any one of claims 1 to 7, wherein the first anti-microbial agent is selected from the group consisting of benzenemethanaminium N-dodecyl-N,N-dimethylchloride, and benzyl-C12-C16-alkyldimethyl-ammoniumchloride.
9. An anti-microbial composition according to any one of claims 6 to 8, wherein the at least one additional anti-microbial agent is selected from the group consisting of amphoteric compounds, iodophores, phenolic compounds, quaternary ammonium compounds, hypochlorites and nitrogen based heterocyclic compounds.
10. An anti-microbial composition according to claim 9, wherein the or each phenolic compound is selected from the group consisting of methyl, ethyl, butyl, halo and aryl substituted phenols.
11. An anti-microbial composition according to claim 9, wherein the or each phenolic compound is selected from the group consisting of 2-phenylphenol, 2-benzyl-4-chlorophenol, 2-cyclopentanol-4-chlorophenol, 4-t-amylphenol, 4-t-butylphenol, 4-chloro-2-pentylphenol, 6-chloro-2-pentylphenol, p-chlorometa-xylenol, 2,4,4-trichloro-2-hydroxydiphenol, thymol, 2-i-propyl-3-methylphenol, chlorothymol, 3-methyl-4-chlorophenol, 2,6-dichloro-4-n-alkyl phenols, 2,4-dichloro-meta-xylenol, 2,4,6-trichlorophenol and 2-benzyl-4-chlorophenol.
12. An anti-microbial composition according to claim 9, wherein the amphoteric compound is selected from the group consisting of dodecyl beta-alanine, dodecyl beta-aminobutyric acid, dodecylamino-di(aminoethylamino)glycine and N-(3-dodecylamino)propylglycine.
13. An anti-microbial composition according to claim 9, wherein the or each iodophore is selected from the group consisting of a complex of iodine or triodine with polyvinylpyrrolidone, a polyether glycol, a polyvinyl alcohol, a polyacrylate, a polyamide, a polyalkylene and a polysaccharide.
14. An anti-microbial composition according to claim 9, wherein the or each hypochlorite is selected from the group consisting of a hypochlorite of an alkali metal and an alkaline earth metal.
15. The anti-microbial composition according to claim 14, wherein the hypochlorite is selected from the group consisting of a hypochlorite of lithium, sodium, potassium and calcium.
16. An anti-microbial composition according to claim 1, comprising a chlorinated trisodium phosphate or a hydrate thereof, chlorine dioxide or a precursor thereof, N,N-dichloro-4-carboxybenzenesulphonamide, 1,3-dichloro-5,5-dimethylhydantoin or a derivative of chloroisocyanuric acid.
17. An anti-microbial composition according to claim 9, wherein the or each nitrogen based heterocyclic compound is selected from the group consisting of a pyridine derivative, a triazole, a thiazole and an imidazole.
18. An anti-microbial composition according to claim 17, wherein the nitrogen based heterocyclic compound is selected from the group consisting of 4-pyridine carboxylic acid hydrazide, sodium 2-pyridinethiol and bis-(2-pyridylthio)zinc-1,1-dioxide.
19. An anti-microbial composition according to any one of claims 1 to 12, comprising from 1 to 4% by volume of the at least one compound (ii).
20. An anti-microbial composition according to any one of claims 1 to 19, wherein the at least one polar solvent is selected from the group consisting of water, isopropanol, diethylene glycol and dipropylene gycol.
21. An anti-microbial composition according to any one of claims 1 to 20, comprising from 1 to 70% by volume of the polar solvent.
22. A formulation comprising the anti-microbial composition according to any one of claims 1 to 21 and a material selected from the group consisting of plastics, fibres, coatings, films, laminates, adhesives, sealants, clays, china, ceramics, concrete, sand, paints, varnishes, lacquers, cleaning agents and settable or curable compositions.
23. A formulation according to claim 22, wherein the formulation comprises from 0.1 to 5.0% by weight of the anti-microbial composition.
24. A formulation according to claim 23, wherein the formulation comprises from 0.5 to 2.0% by weight of the anti-microbial composition.
25. A method of reducing or controlling the formation of colonies of microorganisms on a surface, which method comprises applying the anti-microbial composition according to any one of claims 1 to 21 or a formulation according to any one of claims 22 to 24 to the surface.
26. The use of an anti-microbial composition according to any one of claims 1 to 21 or a formulation according to any one of claims 22 to 24 to reduce or control the formation of colonies of microorganisms on a surface at which it is provided.
27. A method of manufacturing an anti-microbial composition according to any one of claims 1 to 21, the method comprising the steps of (i) mixing the anti-microbial agents together, (ii) adding the at least one compound (ii) to the mixture of step (i), (iii) adding the polar solvent to the mixture of step (ii); and (iv) agitating the resulting mixture until a clear solution is formed.
28. A method of manufacturing a formulation according to any one of claims 22 to 24 comprising the step of adding an anti-microbial composition according to any one of claims 1 to 21 to a material selected from the group consisting of plastics, fibres, coatings, films, laminates, adhesives, sealants, clays, china, ceramics, concrete, sand, paints, varnishes, lacquers, cleaning agents and settable or curable compositions.
CA002433767A 2001-01-04 2002-01-02 Anti-microbial composition Expired - Fee Related CA2433767C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0100155.1 2001-01-04
GB0100155A GB2374011C (en) 2001-01-04 2001-01-04 Anti-microbial composition
US09/756,457 US20020137631A1 (en) 2001-01-04 2001-01-08 Anti-microbial composition
US09/756,457 2001-01-08
PCT/GB2002/000010 WO2002062142A1 (en) 2001-01-04 2002-01-02 Anti-microbial composition

Publications (2)

Publication Number Publication Date
CA2433767A1 CA2433767A1 (en) 2002-08-15
CA2433767C true CA2433767C (en) 2009-09-15

Family

ID=26245528

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002433767A Expired - Fee Related CA2433767C (en) 2001-01-04 2002-01-02 Anti-microbial composition

Country Status (9)

Country Link
US (1) US7674473B2 (en)
EP (1) EP1347684B1 (en)
CN (2) CN1961666B (en)
AT (1) ATE396614T1 (en)
AU (1) AU2002216292B2 (en)
CA (1) CA2433767C (en)
DE (1) DE60226840D1 (en)
ES (1) ES2310595T3 (en)
WO (1) WO2002062142A1 (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7186045B2 (en) 2000-02-16 2007-03-06 L'oreal S.A. Device and method for applying a cosmetic product
WO2005058238A2 (en) * 2003-12-12 2005-06-30 Microban Products Company Antimicrobial composition
ES2245875B1 (en) * 2004-03-26 2006-11-16 Joaquin Espuelas Peñalva MANUFACTURING AND FILTER PROCESS OF NON-WOVEN FABRIC AND / OR FILTERING INJECTED SHEETS OR STRUCTURES OBTAINED BY SUCH PROCESS FOR FILTRATION AND ELIMINATION OF THE PNEUMOFILA LEGIONELLA.
EP1786873B1 (en) * 2004-09-03 2016-11-16 Microban Products Company Antimicrobial cementitious compositions
GB0426308D0 (en) * 2004-12-01 2004-12-29 Byotrol Llc Preservative and embalming fluids
US20080017307A1 (en) * 2005-01-21 2008-01-24 Microban Products Company Antimicrobial overlay sheet and method
US20060207005A1 (en) * 2005-03-16 2006-09-21 Janssen Terrance E Cartridge apparatus for urinal
US9446952B2 (en) * 2005-03-24 2016-09-20 Nalco Company Batch methods for producing chlorine dioxide solutions
GB2432119B (en) * 2005-11-10 2011-03-23 Biotech Internat Ltd Improvements in and relating to biocidal compositions
US20070166403A1 (en) * 2006-01-11 2007-07-19 Amino Solutions, Llc Method and Compound for Treating Mold
CA2656397A1 (en) * 2006-09-05 2008-03-13 University Of Manitoba Antimicrobial coatings
US20140044766A1 (en) * 2007-02-08 2014-02-13 Christophe Baudrion Method for the antimicrobial protection of an object using an antimicrobial pressure-sensitive adhesive plastics film
FR2912417A1 (en) * 2007-02-08 2008-08-15 Hexis Sa METHOD FOR ANTIMICROBIAL PROTECTION OF A SURFACE OF AN OBJECT USING AN ANTIMICORBIAL ADHESIVE PLASTIC FILM
GB0713799D0 (en) * 2007-07-17 2007-08-22 Byotrol Llc Anti-microbial compositions
JP5615708B2 (en) 2007-09-17 2014-10-29 バイオトロル・ピーエルシー Formulation containing antimicrobial composition
WO2009100164A2 (en) * 2008-02-04 2009-08-13 Microban Products Company Antimicrobial sealing element
EP2230226B1 (en) 2009-03-18 2017-01-18 Infineum International Limited Additives for fuel oils
CN104941004B (en) 2009-11-25 2018-09-14 扩散技术公司 The rear loading method of the plastics of zeolite is adulterated with antimicrobial metal ion pair
BR112012016027B1 (en) 2009-12-11 2019-01-15 Difusion Technologies, Inc. production method of polyetheretherketone antimicrobial implants
US9107765B2 (en) 2010-05-07 2015-08-18 Difusion Technologies, Inc. Medical implants with increased hydrophilicity
WO2012119227A1 (en) * 2011-03-04 2012-09-13 Surface Medical Inc. Adhesive patch and method of using the same
US11058793B2 (en) 2011-05-16 2021-07-13 Avery Dennison Corporation Adhesive containing microparticles
CN104053632A (en) * 2011-08-26 2014-09-17 俄亥俄州大学 Compositions and methods for treating biofilms
US20130089621A1 (en) * 2011-10-05 2013-04-11 Arkema Inc. Disinfectant compositions with hydrogen peroxide
US20130089533A1 (en) 2011-10-05 2013-04-11 Arkema Inc. Disinfectant compositions with hydrogen peroxide
DE202013101098U1 (en) 2012-02-02 2014-02-25 Laco Energy Systems Gmbh cleaning device
US8613114B1 (en) 2012-07-25 2013-12-24 2nd Skull, LLC Head guard
BR112015019044B1 (en) 2013-02-07 2022-02-08 Avery Dennison Corporation ANTIMICROBIAL ADHESIVE COMPOSITION, ITS MEDICAL ARTICLE, AND METHOD OF INCREASING THE RELEASE OF AN ANTIMICROBIAL AGENT FROM AN ADHESIVE COMPOSITION
WO2014152649A1 (en) * 2013-03-15 2014-09-25 Difusion Technologies, Inc. Enhanced efficacy self-sterilizing orthopedic implants
EP2968014B1 (en) 2013-03-15 2019-04-24 Avery Dennison Corporation Transparent cover dressing application system and inclusion of label strip
GB2515473A (en) * 2013-06-18 2014-12-31 Robert Timothy Gros Anti microbial inks and sealants
GB2517778B (en) 2013-09-02 2015-08-05 Robert Anthony William Scoones Cleaning liquid
EP3151813B1 (en) 2014-06-05 2020-12-09 Avery Dennison Corporation Articles with active agent concentrated at the substrate contacting surface and related methods
DE202014102819U1 (en) 2014-06-19 2014-06-26 Larco Energy Systems Gmbh cleaning device
CN104845742A (en) * 2015-05-05 2015-08-19 柳州立洁科技有限公司 Weakly alkaline antibacterial floor cleaning agent
EP3344740A4 (en) 2015-09-03 2019-04-17 The Administrators of The Tulane Educational Fund Compositions and methods for multipurpose disinfection and sterilization solutions
US10501587B2 (en) * 2016-07-19 2019-12-10 Cupron, Inc. Processes for producing an antimicrobial masterbatch and products thereof
US10864058B2 (en) 2018-03-28 2020-12-15 Parasol Medical, Llc Antimicrobial treatment for a surgical headlamp system
US20200071540A1 (en) * 2018-09-04 2020-03-05 Parasol Medical LLC Antimicrobial coating applied to protective body equipment such as helmets, shoulder pads, and elbow pads
CN113260347B (en) * 2018-12-21 2023-10-31 联合利华知识产权控股有限公司 Antimicrobial compositions comprising modified clay and bisphenol
KR102077726B1 (en) * 2019-05-23 2020-02-17 주식회사 엘브스바이오켐 Anti-freezing antimicrobial agent composite and preparation method for the same
US20210137120A1 (en) * 2019-11-11 2021-05-13 Parasol Medical, Llc Sanitizing and antimicrobial solution with silane quaternary ammonium with hypochlorous acid
US20220174945A1 (en) * 2020-12-09 2022-06-09 GMR Labs, LLC Apparatus and method for protecting against microbial hazards
CN115299437A (en) * 2021-05-06 2022-11-08 南顺商标有限公司 Antimicrobial compositions and methods of making the same

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1460279A (en) * 1973-05-10 1976-12-31 Ici Ltd Biocidal compositions
US4173643A (en) * 1973-12-20 1979-11-06 Rohm And Haas Company Synergistic microbiocidal compositions
CA1087955A (en) * 1976-01-12 1980-10-21 Phillip E. Sokol Cleansing-sanitizing composition
US4698148A (en) 1981-06-17 1987-10-06 James Keane Removal of chlorine-based contaminants from materials contaminated the same
US4631273A (en) 1984-11-05 1986-12-23 Dow Corning Corporation Aqueous emulsions using cationic silanes
JPS61148285A (en) 1984-12-21 1986-07-05 Toray Silicone Co Ltd Solid material treating agent composition
JPH0672081B2 (en) 1985-06-07 1994-09-14 三菱瓦斯化学株式会社 Plant growth promoter
JPH064761B2 (en) 1986-03-19 1994-01-19 東亜道路工業株式会社 Asphalt-polyol emulsion and method for producing the same
US4718941A (en) 1986-06-17 1988-01-12 The Regents Of The University Of California Infiltration processing of boron carbide-, boron-, and boride-reactive metal cermets
US4788176A (en) 1986-12-29 1988-11-29 Aluminum Company Of America Adsorbent comprising metal oxide/hydroxide particles reacted with one or more phosphorous-containing materials having selected organic radicals attached thereto
US5178495A (en) 1987-07-24 1993-01-12 Reef Industries, Inc. Polymeric film with biocide
US5856245A (en) 1988-03-14 1999-01-05 Nextec Applications, Inc. Articles of barrier webs
US5874164A (en) 1988-03-14 1999-02-23 Nextec Applications, Inc. Barrier webs having bioactive surfaces
US5869172A (en) 1988-03-14 1999-02-09 Nextec Applications, Inc. Internally-coated porous webs with controlled positioning of modifiers therein
US4822511A (en) * 1988-05-06 1989-04-18 Rohm And Haas Company Preservative compositions comprising a synergistic mixture of isothiagolones
WO1991007090A1 (en) * 1989-11-16 1991-05-30 Henkel Kommanditgesellschaft Auf Aktien Combatting slime-forming microorganisms
DE69128716T2 (en) 1990-07-18 1998-08-13 Univ Australian EDUCATION POROUS MATERIALS
GB9018654D0 (en) * 1990-08-24 1990-10-10 Reckitt & Colmann Prod Ltd Method of disinfection
IT1247918B (en) * 1991-05-10 1995-01-05 Germo Spa MULTI-PURPOSE DISINFECTANT COMPOSITIONS
AU650564B2 (en) 1991-06-07 1994-06-23 Minnesota Mining And Manufacturing Company Disinfecting shampoo composition for animals
US5326492A (en) 1991-11-18 1994-07-05 Medical Polymers, Inc. Disinfectant mixture containing water soluble lubricating and cleaning agents and method
US5244666A (en) * 1992-02-04 1993-09-14 Consolidated Chemical, Inc. Presurgical skin scrub and disinfectant
US5538667A (en) 1993-10-28 1996-07-23 Whitehill Oral Technologies, Inc. Ultramulsions
US5834114A (en) 1995-05-31 1998-11-10 The Board Of Trustees Of The University Of Illinois Coated absorbent fibers
US5711936A (en) 1995-06-05 1998-01-27 Whitehill Oral Technologies, Inc. Ultramulsion based ingestible compositions
US5733529A (en) 1995-06-05 1998-03-31 Whitehill Oral Technologies, Inc. Ultramulsion based antigingivitis toothpaste compositions
US5651959A (en) 1995-06-05 1997-07-29 Whitehill Oral Technologies, Inc. Ultramulsion based oral care compositions
AU6155696A (en) 1995-06-05 1996-12-24 Whitehill Oral Technologies, Inc. Ultramulsion based paint and coating products
US5733536A (en) 1995-06-05 1998-03-31 Whitehill Oral Technologies, Inc. Ultramulsion based hair care compositions
US5730967A (en) 1995-06-05 1998-03-24 Whitehill Oral Technologies, Inc. Ultramulsion based skin care compositions
US5645841A (en) 1995-06-05 1997-07-08 Whitehill Oral Technologies, Inc. Ultramulsion based oral care rinse compositions
US5665374A (en) 1995-06-05 1997-09-09 Whitehill Oral Technologies, Inc. Ultramulsion containing interdental delivery devices
US5688449A (en) 1995-10-02 1997-11-18 Nitech Corporation Method of forming and extruding an additive-coated resin composition
US5681637A (en) 1996-02-01 1997-10-28 Aller-Gard 100 Products, Inc. Microorganism resistant pile weatherstripping
US5670055A (en) * 1996-08-08 1997-09-23 Nalco Chemical Company Use of the linear alkylbenzene sulfonate as a biofouling control agent
US6039965A (en) * 1996-09-27 2000-03-21 Calgon Corporation Surfanctants for reducing bacterial adhesion onto surfaces
GR1002937B (en) * 1997-02-14 1998-07-13 New chemical compound with several applications - method of production thereof
US5955093A (en) 1997-06-09 1999-09-21 The Procter & Gamble Company Uncomplexed cyclodextrin compositions for odor control
US6656923B1 (en) * 1997-06-09 2003-12-02 The Procter & Gamble Company Uncomplexed cyclodextrin compositions for odor and wrinkle control
US6107268A (en) 1999-04-16 2000-08-22 Kimberly-Clark Worldwide, Inc. Sorbent material
GB2338651A (en) 1998-06-27 1999-12-29 Woollard Trevor P Liquid polymer composition
US6187327B1 (en) 1999-05-19 2001-02-13 Kevin Stack Antimicrobial sanitizing lotion with skin protection properties

Also Published As

Publication number Publication date
DE60226840D1 (en) 2008-07-10
WO2002062142A1 (en) 2002-08-15
AU2002216292B2 (en) 2007-08-30
EP1347684A1 (en) 2003-10-01
US20030031687A1 (en) 2003-02-13
CN1961666B (en) 2011-06-22
EP1347684B1 (en) 2008-05-28
ATE396614T1 (en) 2008-06-15
CN1491079A (en) 2004-04-21
ES2310595T3 (en) 2009-01-16
CA2433767A1 (en) 2002-08-15
CN1302707C (en) 2007-03-07
CN1961666A (en) 2007-05-16
US7674473B2 (en) 2010-03-09

Similar Documents

Publication Publication Date Title
CA2433767C (en) Anti-microbial composition
AU2002216292A1 (en) Anti-microbial composition
US20020137631A1 (en) Anti-microbial composition
JP5631735B2 (en) Antibacterial composition
EP2308308B1 (en) Stable aqueous solutions of silane quat ammonium compounds
EP1779727A1 (en) Antibacterial composition, antibacterial molding, solution containing antibacterial composition, detergent, surface of tatami mat and tatami mat
US8728540B2 (en) Stable aqueous solutions of silane quat ammonium compounds
WO2012037615A1 (en) An improved antimicrobial agent and method of maintaining microbial control
JP2004137241A (en) Antibacterial/mildew-proofing/algicidal composition
JP2004339102A (en) Antibacterial, mildewproofing, anti-algal composition
WO2010043863A2 (en) Anti-microbial composition
JP2007211004A (en) Dispersion, surface coating treatment agent and laser surface treatment agent
JP2003095828A (en) Industrial antibacterial composition and antibacterial method
JP4713937B2 (en) Antibacterial composition, antibacterial molded article, antibacterial composition-containing solution, cleaning agent, and tatami mat
GB2338651A (en) Liquid polymer composition
AU2010101184A4 (en) An improved antimicrobial agent
JP2003073213A (en) Industrial antibacterial composition and antibacterial method
JP2003095831A (en) Industrial antibacterial composition and antibacterial method
Lee Antimicrobial Agents and Applications on Polymeric Materials
BRPI0814611B1 (en) COMPOSITION, PROCESS FOR PREPARING A COMPOSITION, AND USE OF A COMPOSITION
JP2003063916A (en) Antibacterial composition for industrial use and antibacterial treatment method

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160104